Next Article in Journal
Tracking the Continuous Evolutionary Processes of an Endogenous Retrovirus of the Domestic Cat: ERV-DC
Next Article in Special Issue
Characterizing Phage Genomes for Therapeutic Applications
Previous Article in Journal / Special Issue
Criteria for Selecting Suitable Infectious Diseases for Phage Therapy

Volume 10, Issue 4

► Article Menu
Issue 4 (April) cover image

Article Versions

Related Info

More by Authors

Export Article

Open AccessConference Report
Viruses 2018, 10(4), 178; https://doi.org/10.3390/v10040178

Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains

1,†,‡
, 2,†,‡
, 3,†,‡
, 4,†
, 5
, 6
, 7,8
, 6
, 9
, 10
, 11,12
, 13
, 14
, 10
, 15
, 16
, 3,17
, 16
, 3
, 16,18
, 3
, 3
and 10,*
1
Department of Microorganisms, Leibniz Institute DSMZ—German Collection of Microorganisms and Cell Cultures, 38100 Braunschweig, Germany
2
Department of Fundamental Microbiology, University of Lausanne, 1015 Lausanne, Switzerland
3
Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, 1120 Brussels, Belgium
4
Laboratory of Gene Technology, Department of Biosystems, 3000 Leuven, Belgium
5
Department of Microbiology, Institut Pasteur, 75015 Paris, France
6
Faculty of Dental Medicine, The Hebrew University of Jerusalem, Jerusalem 9112001, Israel
7
Bacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland
8
Department of Clinical Immunology, Transplantation Institute, Medical University of Warsaw, 02-006 Warsaw, Poland
9
Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium
10
Eliava Institute of Bacteriophage, Microbiology and Virology, Gotua Street 3, 0160 Tbilisi, Georgia
11
Institute of Biochemistry and Biophysics, Polish Academy of Sciences, 00-901 Warsaw, Poland
12
Autonomous Department of Microorganisms’ Biology, Faculty of Agriculture and Biology, Warsaw University of Life Sciences—SGGW, 02-787 Warsaw, Poland
13
University of Turin, 10124 Turin, Italy
14
Centre of Excellence in Biological Interactions, Department of Biological and Environmental Science, Nanoscience Center, University of Jyväskylä, Survontie 9C, FI-40014 Jyväskylä, Finland
15
Chemical Engineering Department, Loughborough University, Leicestershire LE11 3TU, UK
16
Department of Experimental Biology, Faculty of Science, Masaryk University, 60000 Brno, Czech Republic
17
Laboratory for Bacteriology Research, Faculty Medicine & Health Sciences, Ghent University, 9000 Ghent, Belgium
18
MB Pharma, 120 00 Prague 2 Vinohrady, Czech Republic
†
These authors contributed equally to this work.
‡
Chair persons of the round tables.
*
Author to whom correspondence should be addressed.
Received: 31 March 2018 / Revised: 3 April 2018 / Accepted: 3 April 2018 / Published: 5 April 2018
(This article belongs to the Special Issue Hurdles for Phage Therapy (PT) to Become a Reality)
Full-Text   |   PDF [322 KB, uploaded 3 May 2018]

Abstract

Phage therapy is increasingly put forward as a “new” potential tool in the fight against antibiotic resistant infections. During the “Centennial Celebration of Bacteriophage Research” conference in Tbilisi, Georgia on 26–29 June 2017, an international group of phage researchers committed to elaborate an expert opinion on three contentious phage therapy related issues that are hampering clinical progress in the field of phage therapy. This paper explores and discusses bacterial phage resistance, phage training and the presence of prophages in bacterial production strains while reviewing relevant research findings and experiences. Our purpose is to inform phage therapy stakeholders such as policy makers, officials of the competent authorities for medicines, phage researchers and phage producers, and members of the pharmaceutical industry. This brief also points out potential avenues for future phage therapy research and development as it specifically addresses those overarching questions that currently call for attention whenever phages go into purification processes for application. View Full-Text
Keywords: Bacteriophage; phage therapy; resistance; adaptation; prophage; production; regulation Bacteriophage; phage therapy; resistance; adaptation; prophage; production; regulation
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Rohde, C.; Resch, G.; Pirnay, J.-P.; Blasdel, B.G.; Debarbieux, L.; Gelman, D.; Górski, A.; Hazan, R.; Huys, I.; Kakabadze, E.; Łobocka, M.; Maestri, A.; Almeida, G.M.F.; Makalatia, K.; Malik, D.J.; Mašlaňová, I.; Merabishvili, M.; Pantucek, R.; Rose, T.; Štveráková, D.; Van Raemdonck, H.; Verbeken, G.; Chanishvili, N. Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains. Viruses 2018, 10, 178.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert

Further Information

Article Processing Charges Pay an Invoice Open Access Policy Terms of Use Terms and Conditions Privacy Policy Contact MDPI Jobs at MDPI

Guidelines

For Authors For Reviewers For Editors For Librarians For Publishers For Societies

MDPI Initiatives

Institutional Open Access Program (IOAP) Sciforum Preprints Scilit MDPI Books Encyclopedia MDPI Blog

Follow MDPI

LinkedIn Facebook Twitter Google+
Back to Top